Ten-fold dilutions of exponentially growing cultures of BY4742 cells transformed with plasmids carrying the different chimeric constructions under the GAL10 promoter were spotted onto SD (-) or SG (+) agar supplemented with 20 mg/l histidine, 20 mg/l lysine and 60 mg/l leucine. The cells were incubated at 30°C for 3 days. (B) BY4742 cells expressing the different chimeric proteins (6 hours of expression) were collected for total-protein extracts. Equal quantities of proteins were separated by SDS-PAGE on a 12% polyacrylamide gel, transferred onto a nitrocellulose membrane and exposed to anti-Ab (Tebu) antibodies.
Fig. S2. Yeast mutants modulate Ab toxixity without changing its protein level. (A)
Ten-fold dilutions of exponentially growing cultures of deleted strains transformed with plasmids carrying the different chimeric constructions under the GAL10 promoter were spotted on the same plate onto SD (-) or SG (+) agar supplemented with 20 mg/l histidine, 20 mg/l lysine and 60 mg/l leucine. (B) Cells expressing the different chimeric proteins (6 hours of expression) were collected for total-protein extracts. Equal quantities of proteins were separated by SDS-PAGE on a 12% polyacrylamide gel, transferred onto a nitrocellulose membrane, and then exposed to monoclonal anti-GFP antibodies (Sigma). Wild-type or RFP-tagged strains were grown for 6 hours in SG liquid medium supplemented with 0.67% casaminoacids to induce the expression of the chimeric proteins and were then examined by epifluorescence microscopy. his3∆1, leu2 ∆0, lys2 ∆0, ura3∆0, Peter Arvidson ∆yap1801/∆yap1802 MATa, his3∆1, leu2∆0, ura3∆0, YHR161C::KanMX4, YGR241C::KanMX4 This study Table S1 . Yeast strains used in this study. Table S2 . Oligonucleotides used in this study.
